Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To determine black-white differences in 1-year recurrent stroke and 30-day case fatality after a recurrent stroke in older US adults.
Methods We conducted a retrospective cohort study using a 5% random sample of Medicare beneficiaries with fee-for-service health insurance coverage who were hospitalized for ischemic stroke between 1999 and 2013. Hazard ratios for recurrent ischemic stroke and risk ratios for 30-day case fatality comparing blacks to whites were calculated with adjustment for demographics, risk factors, and competing risk of death when appropriate.
Results Among 128,789 Medicare beneficiaries having an ischemic stroke (mean age 80 years [SD 8 years], 60.4% male), 11.1% were black. The incidence rate of recurrent ischemic stroke per 1,000 person-years for whites and blacks was 108 (95% confidence interval [CI], 106–111) and 154 (95% CI 147–162) , respectively. The multivariable-adjusted hazard ratio for recurrent stroke among blacks compared with whites was 1.36 (95% CI 1.29–1.44). The case fatality after recurrent stroke for blacks and whites was 21% (95% CI 21%–22%) and 16% (95% CI 15%–18%), respectively. The multivariable-adjusted relative risk for mortality within 30 days of a recurrent stroke among blacks compared with whites was 0.82 (95% CI 0.73–0.93).
Conclusion The risk of stroke recurrence among older Americans hospitalized for ischemic stroke is higher for blacks compared to whites, while 30-day case fatality after recurrent stroke remains lower for blacks.
Glossary
- CI=
- confidence interval;
- HR=
- hazard ratio;
- ICD-9-CM=
- International Classification of Diseases, 9th edition, clinical modification;
- NOMAS=
- Northern Manhattan Study;
- PRoFESS=
- Prevention Regimen for Effectively Avoiding Second Strokes;
- PROGRESS=
- Perindopril Protection Against Recurrent Stroke Study;
- REGARDS=
- Reasons for Geographic and Racial Differences in Stroke;
- RR=
- relative risk;
- SPARCL=
- Stroke Prevention by Aggressive Reduction in Cholesterol Levels;
- VISP=
- Vitamin Intervention for Stroke Prevention
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received January 27, 2018.
- Accepted in final form July 26, 2018.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrenceLuciano A. Sposato, Joshua O. Cerasuolo, Lauren E. Cipriano et al.Neurology, February 14, 2018 -
Article
Total small vessel disease score and risk of recurrent strokeValidation in 2 large cohortsKui Kai Lau, Linxin Li, Ursula Schulz et al.Neurology, May 17, 2017 -
Article
Effect of coexisting vascular disease on long-term risk of recurrent events after TIA or strokeMarion Boulanger, Linxin Li, Shane Lyons et al.Neurology, July 23, 2019 -
Article
Recurrent thromboembolic events after ischemic stroke in patients with cancerBabak B. Navi, Samuel Singer, Alexander E. Merkler et al.Neurology, May 21, 2014